A new initiative has been launched in the UAE to support low-income expatriates battling cancer and multiple sclerosis.
They will be provided with medication as part of the Ministry of Health and Prevention's (MOHAP) new agreement with the pharmaceutical firm Merck Serono, and Manzil Healthcare Services.
The programme will benefit patients diagnosed with colorectal, head and neck, and urothelial cancer, as well as multiple sclerosis.
It aims to support those who don't have medical insurance and those with partial coverage.
"The initiative is one of a series of memoranda of understanding signed by the ministry to improve the services provided to low-income patients and secure their access to high-quality medicines," said Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector at MOHAP.
"It will help doctors follow the best practices in the treatment plan, and enable patients to follow up and complete their treatment plan," he added.
Over 3.5 million interactions on BRIDGE Summit's App in opening day
UAE launches new AI ecosystem to support farmers
UAE sets model for providing highly efficient healthcare, says WHO
BRIDGE Summit opens with global media leaders and 60,000 participants
H.H. Sheikh Khaled attends opening of Abu Dhabi Finance Week
H.H. Sheikh Hamdan approves Dubai residential planning model
Global leaders pledge $1.9 billion in Abu Dhabi to end polio
RTA expands trial taxi ride-sharing services
